NVST · Envista Holdings Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $705.50M | - | $669.90M | $682.10M | $616.90M | - | $601.00M | $633.10M | $623.60M | - |
| Cost of Revenue | $315.40M | - | $299.70M | $312.20M | $280.90M | - | $283.70M | $306.50M | $267.30M | - |
| Gross Profit | $390.10M | - | $370.20M | $369.90M | $336.00M | - | $317.30M | $326.60M | $356.30M | - |
| R&D | $30.00M | - | $28.30M | $28.30M | $25.30M | - | $25.50M | $23.60M | $23.30M | - |
| SG&A | $297.60M | - | $284.40M | $295.30M | $271.70M | - | $270.90M | $302.50M | $284.90M | - |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $29.20M | - | $29.20M | $29.80M | $32.10M | - | - | - | $9.50M | - |
| Operating Income | $62.50M | - | $57.50M | $46.30M | $39.00M | - | $20.90M | ($1.15B) | $48.10M | - |
| Interest Expense | - | - | - | - | - | - | - | $17.40M | $12.90M | - |
| Income Tax | $13.50M | - | $80.20M | $14.30M | $11.00M | - | $1.40M | ($14.50M) | $11.70M | - |
| Net Income | $38.70M | - | ($30.30M) | $26.40M | $18.00M | - | $8.20M | ($1.15B) | $23.60M | - |
| EPS - Basic | $0.24 | - | ($0.18) | $0.16 | $0.10 | - | $0.05 | ($6.69) | $0.14 | - |
| EPS - Diluted | $0.23 | - | ($0.18) | $0.16 | $0.10 | - | $0.05 | ($6.69) | $0.14 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.08B | $1.21B | $1.13B | $1.11B | $1.08B | $1.07B | $991.30M | $1.04B | $948.50M | $940.00M |
| Accounts Receivable | $436.60M | $429.60M | $405.90M | $422.80M | $393.10M | $363.00M | $392.10M | $380.60M | $413.00M | $407.50M |
| Inventory | $300.30M | $288.10M | $290.80M | $281.90M | $261.30M | $241.00M | $265.60M | $263.80M | $267.40M | $258.80M |
| Accounts Payable | $170.00M | $191.60M | $156.00M | $171.80M | $163.50M | $174.60M | $172.10M | $172.40M | $174.70M | $179.50M |
| Current Assets | $1.92B | $2.03B | $1.95B | $1.93B | $1.85B | $1.79B | $1.80B | $1.82B | $1.77B | $1.74B |
| Total Assets | $5.58B | $5.68B | $5.64B | $5.66B | $5.47B | $5.35B | $5.51B | $5.44B | $6.56B | $6.61B |
| Current Liabilities | $786.60M | $852.60M | $821.70M | $793.90M | $873.30M | $878.70M | $865.50M | $821.40M | $781.30M | $780.80M |
| Long-term Debt | $1.44B | $1.45B | $1.45B | $1.45B | $1.30B | $1.28B | $1.31B | $1.39B | $1.39B | $1.40B |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $3.08B | $3.11B | $3.09B | $3.14B | $3.04B | $2.93B | $4.29B | $2.98B | $4.14B | $4.17B |
| Retained Earnings | ($401.70M) | ($440.40M) | ($473.30M) | ($443.00M) | ($469.40M) | ($487.40M) | ($488.60M) | ($496.80M) | $654.80M | $631.20M |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ($3.30M) | - | - | - | $300.0K | - | - | - | $40.30M | - |
| Investing Cash Flow | ($68.90M) | - | - | - | ($8.80M) | - | - | - | ($10.70M) | - |
| Financing Cash Flow | ($45.60M) | - | - | - | ($17.60M) | - | - | - | ($2.60M) | - |
| CapEx | $12.50M | - | - | - | $5.90M | - | - | - | $11.00M | - |
| Free Cash Flow | ($15.80M) | - | - | - | ($5.60M) | - | - | - | $29.30M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 55.3% | - | 55.3% | 54.2% | 54.5% | - | 52.8% | 51.6% | 57.1% | - |
| Operating margin | 8.9% | - | 8.6% | 6.8% | 6.3% | - | 3.5% | -182.2% | 7.7% | - |
| EBITDA margin | 13.0% | - | 12.9% | 11.2% | 11.5% | - | - | - | 9.2% | - |
| Net margin | 5.5% | - | -4.5% | 3.9% | 2.9% | - | 1.4% | -181.9% | 3.8% | - |
| Free cash flow margin | -2.2% | - | - | - | -0.9% | - | - | - | 4.7% | - |
| FCF / Net income | -0.41 | - | - | - | -0.31 | - | - | - | 1.24 | - |
| R&D / Revenue | 4.3% | - | 4.2% | 4.1% | 4.1% | - | 4.2% | 3.7% | 3.7% | - |
| SG&A / Revenue | 42.2% | - | 42.5% | 43.3% | 44.0% | - | 45.1% | 47.8% | 45.7% | - |
| Effective tax rate | 25.9% | - | 160.7% | 35.1% | 37.9% | - | 14.6% | - | 33.1% | - |
| Return on assets | 0.7% | - | -0.5% | 0.5% | 0.3% | - | 0.1% | -21.2% | 0.4% | - |
| Return on equity | 1.3% | - | -1.0% | 0.8% | 0.6% | - | 0.2% | -38.7% | 0.6% | - |
| Return on invested capital | 1.0% | - | 0.6% | 0.7% | 0.6% | - | 0.3% | -20.9% | 0.6% | - |
| Liquidity | ||||||||||
| Current ratio | 2.44 | 2.38 | 2.37 | 2.44 | 2.12 | 2.04 | 2.08 | 2.22 | 2.27 | 2.23 |
| Quick ratio | 2.06 | 2.04 | 2.02 | 2.08 | 1.82 | 1.76 | 1.77 | 1.90 | 1.93 | 1.90 |
| Cash ratio | 1.38 | 1.42 | 1.38 | 1.40 | 1.23 | 1.22 | 1.15 | 1.26 | 1.21 | 1.20 |
| Leverage | ||||||||||
| Debt / Equity | 0.47 | 0.47 | 0.47 | 0.46 | 0.43 | 0.44 | 0.30 | 0.47 | 0.34 | 0.33 |
| Debt / Assets | 0.26 | 0.26 | 0.26 | 0.26 | 0.24 | 0.24 | 0.24 | 0.26 | 0.21 | 0.21 |
| Debt / EBITDA | 15.69 | - | 16.67 | 18.99 | 18.23 | - | - | - | 24.14 | - |
| Interest coverage | - | - | - | - | - | - | - | -66.3x | 3.7x | - |
| Equity multiplier | 1.81 | 1.83 | 1.83 | 1.80 | 1.80 | 1.82 | 1.28 | 1.83 | 1.58 | 1.58 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | 0.13 | - | 0.12 | 0.12 | 0.11 | - | 0.11 | 0.12 | 0.10 | - |
| Inventory turnover | 1.05 | - | 1.03 | 1.11 | 1.08 | - | 1.07 | 1.16 | 1.00 | - |
| Days sales outstanding | 226d | - | 221d | 226d | 233d | - | 238d | 219d | 242d | - |
| Days inventory outstanding | 348d | - | 354d | 330d | 340d | - | 342d | 314d | 365d | - |
| Days payable outstanding | 197d | - | 190d | 201d | 212d | - | 221d | 205d | 239d | - |
| Cash conversion cycle | 377d | - | 385d | 355d | 360d | - | 358d | 328d | 368d | - |
| Valuation | ||||||||||
| P / E | 112.2x | - | - | 122.9x | 169.7x | - | 395.2x | - | 152.7x | - |
| P / B | 1.4x | - | 1.1x | 1.1x | 1.0x | - | 0.8x | 1.0x | 0.9x | - |
| P / S | 6.1x | - | 5.0x | 4.9x | 4.8x | - | 5.7x | 4.5x | 5.9x | - |
| EV / EBITDA | 50.7x | - | 42.6x | 48.3x | 44.5x | - | - | - | 72.0x | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 14.4% | - | 11.5% | 7.7% | -1.1% | - | -4.8% | -4.4% | -0.6% | - |
| Revenue CAGR (3y) | 4.0% | - | 2.0% | 1.8% | -0.8% | - | -0.3% | -5.1% | -4.2% | - |
| Revenue CAGR (5y) | -0.1% | - | 0.9% | 13.5% | 2.4% | - | -2.4% | - | - | - |
| Gross profit growth (YoY) | 16.1% | - | 16.7% | 13.3% | -5.7% | - | -12.7% | -13.7% | -1.8% | - |
| Operating income growth (YoY) | 60.3% | - | 175.1% | - | -18.9% | - | -74.9% | - | -33.3% | - |
| Net income growth (YoY) | 115.0% | - | - | - | -23.7% | - | -61.9% | - | -46.1% | - |
| EPS growth (YoY) | 130.0% | - | - | - | -28.6% | - | -58.3% | - | -44.0% | - |
| EPS CAGR (3y) | -2.7% | - | - | -14.9% | -38.0% | - | -54.2% | - | -30.1% | - |
| EPS CAGR (5y) | -10.9% | - | - | - | - | - | -36.9% | - | - | - |
| FCF growth (YoY) | -182.1% | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 1.4% | 5.8% | -28.1% | 5.5% | -26.7% | -29.7% | 0.0% | -31.0% | -3.2% | -0.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$2.72B totalSpecialty Productsand Technologies$1.75B · 64.5%
Equipmentand Consumables$966.70M · 35.5%
Geographic
$4.47B totalUS$1.28B · 28.6%
All Other Countries$1.24B · 27.8%
North America$720.50M · 16.1%
Western Europe$498.00M · 11.1%
High Growth Markets$444.80M · 9.9%
CN$194.40M · 4.3%
Other Developed Markets$89.50M · 2.0%
Peer comparison
Same SIC group: Dental Equipment & Supplies
Comparing Envista Holdings Corp against the 5 most active filers in the same SIC group.